Advances in Molecular Pathology
暫譯: 分子病理學的進展

Felipe Simon, Ph.D., is currently Full Professor of the Faculty of Life Sciences in Universidad Andres Bello, at Santiago, Chile, and Researcher at the Millennium Institute of Immunology and Immunotherapy. His line of research is mainly focused on understanding the molecular mechanisms involved in systemic inflammatory syndromes, with a special interest in vascular and immune dysfunction, to identify suitable molecular targets and develop new and more efficient therapies to tackle organ damage and mortality. He has published more than 100 articles with more than 3,800 citations and has an H-index=40 (Google Scholar, 2022). He has been conferred several awards, participated as Expert Evaluator in numerous accreditation committees, and is currently Director of Research of the Faculty of Life Sciences at Universidad Andres Bello. He is Member of Chilean Society of Physiological Science and the American Physiological Society.

Carmelo Bernabeu, Ph.D., is Research Professor at the Spanish National Research Council since 2003. His scientific interest focuses on cardiovascular diseases involving endoglin, a cell surface receptor present in endothelial cells. Among them are: hereditary hemorrhagic telangiectasia (HHT), a vascular disease caused by heterozygous mutations in the endoglin gene; and preeclampsia, a disease affecting pregnant women and associated with hypertension and proteinuria, in which a pathogenic role has been described for elevated levels of a circulating form of endoglin. He has worked in different US universities and research centers, including the University of California at Los Angeles, Harvard University Medical School in Boston, and University of Utah in Salt Lake City. He has published more than 200 articles with more than 18,000 citations and has an H-index=71 (Google Scholar, 2022). He is Editor of several international journals in the area of Biomedicine and is current Member and past Chair of the Global Research and Medical Advisory Boardof the Hereditary Hemorrhagic Telangiectasia Foundation.

費利佩·西蒙（Felipe Simon），博士，目前是智利聖地亞哥安德烈斯·貝略大學（Universidad Andres Bello）生命科學院的正教授，並且是千禧免疫學與免疫治療研究所的研究員。他的研究方向主要集中在理解系統性炎症綜合症中涉及的分子機制，特別關注血管和免疫功能障礙，以識別合適的分子靶點並開發新的、更有效的療法來應對器官損傷和死亡率。他已發表超過100篇文章，引用次數超過3,800次，H指數為40（Google Scholar，2022年）。他獲得了多項獎項，並作為專家評估員參與了多個認證委員會，目前擔任安德烈斯·貝略大學生命科學院的研究主任。他是智利生理科學學會和美國生理學會的成員。

卡梅洛·伯納比（Carmelo Bernabeu），博士，自2003年以來擔任西班牙國家研究委員會的研究教授。他的科學興趣集中在涉及內皮細胞表面受體內源素（endoglin）的心血管疾病上。其中包括：遺傳性出血性毛細血管擴張症（HHT），這是一種由內源素基因的雜合突變引起的血管疾病；以及妊娠高血壓症（preeclampsia），這是一種影響孕婦的疾病，與高血壓和蛋白尿有關，並且已描述內源素的循環形式升高在其中具有致病作用。他曾在美國的不同大學和研究中心工作，包括加州大學洛杉磯分校、哈佛大學醫學院和猶他大學。他已發表超過200篇文章，引用次數超過18,000次，H指數為71（Google Scholar，2022年）。他是多本生物醫學領域國際期刊的編輯，並且是遺傳性出血性毛細血管擴張症基金會全球研究與醫療諮詢委員會的現任成員及前任主席。